These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9062075)

  • 1. The immunosuppressory and adhesive miniregion of the human major histocompatibility protein, human leukocyte antigen DQ.
    Szewczuk Z; Stefanowicz P; Wilczyński A; Siemion IZ; Cierniewski CS; Kralisz U; Wieczorek Z
    Biopolymers; 1996; 40(5):571-83. PubMed ID: 9062075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressory mini-regions of HLA-DP and HLA-DR.
    Szewczuk Z; Wilczyński A; Stefanowicz P; Fedorowicz W; Siemion IZ; Wieczorek Z
    Mol Immunol; 1999 Jun; 36(8):525-33. PubMed ID: 10475607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological properties of the thymopentin-like fragments of HLA-DQ.
    Szewczuk Z; Siemion IZ; Wieczorek Z
    Mol Immunol; 1996 Aug; 33(11-12):903-8. PubMed ID: 8960113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further investigations on thymopentin-like fragments of HLA-DQ and their analogs.
    Szewczuk Z; Wieczorek Z; Stefanowicz P; Wilczyński A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):335-41. PubMed ID: 9523010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressory activity of the cyclodimeric peptide with RGD-sequences.
    Szewczuk Z; Buczek P; Stefanowicz P; Krajewski K; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2001; 48(1):121-30. PubMed ID: 11440161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressory activity of ubiquitin fragments containing retro-RGD sequence.
    Szewczuk Z; Stefanowicz P; Wilczyński A; Staszewska A; Siemion IZ; Zimecki M; Wieczorek Z
    Biopolymers; 2004 Aug; 74(5):352-62. PubMed ID: 15222015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New conformationally restricted analog of the immunosuppressory mini-domain of HLA-DQ and its biological properties.
    Szewczuk Z; Wilczyński A; Dyba M; Petry I; Siemion IZ; Wieczorek Z
    Peptides; 2000 Dec; 21(12):1849-58. PubMed ID: 11150645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive activity of alanine analogs of cyclolinopeptide A.
    Wieczorek Z; Zimecki M; Pedyczak A; Lisowski M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):291-6. PubMed ID: 8010868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonated analogues of cyclolinopeptide A. Synthesis, immunosuppressive activity and CD studies.
    Cebrat M; Lisowski M; Siemion IZ; Zimecki M; Wieczorek Z
    J Pept Res; 1997 May; 49(5):415-20. PubMed ID: 9211222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DQ7 beta(1) and beta(2) derived peptides as immunomodulators.
    Skarlas T; Panou-Pomonis E; Kluczyk A; Szewczuk Z; Zimecki M; Kosmopoulou A; Sakarellos-Daitsiotis M; Sakarellos C
    J Pept Sci; 2009 Apr; 15(4):296-304. PubMed ID: 19206073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunosuppressive mini-domain of human lactoferrin.
    Siemion IZ; Sloń J; Wieczorek Z
    J Pept Sci; 1995; 1(5):295-302. PubMed ID: 9223008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive activity of threonine-containing analogues of cyclolinopeptide A.
    Siemion IZ; Cebrat M; Lisowski M; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):257-61. PubMed ID: 1340179
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological studies on analogs of cyclolinopeptide A with a shortened peptide chain.
    Siemion IZ; Pedyczak A; Strug I; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):459-65. PubMed ID: 8572907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of a new bridged immunosuppressor.
    Szewczuk Z; Wilczyński A; Petry I; Siemion IZ; Wieczorek Z
    Acta Biochim Pol; 2001; 48(4):1147-50. PubMed ID: 11995982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimerization of the immunosuppressive peptide fragment of HLA-DR molecule enhances its potency.
    Szewczuk Z; Biernat M; Dyba M; Zimecki M
    Peptides; 2004 Feb; 25(2):207-15. PubMed ID: 15063002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
    Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and immunosuppressive activity of glycine containing linear analogs of cyclolinopeptide A.
    Siemion IZ; Cebrat M; Pédyczak A; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):285-9. PubMed ID: 8010867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfide and amide-bridged cyclic peptide analogues of the VEGF₈₁₋₉₁ fragment: synthesis, conformational analysis and biological evaluation.
    García-Aranda MI; Mirassou Y; Gautier B; Martín-Martínez M; Inguimbert N; Vidal M; García-López MT; Jiménez MA; González-Muñiz R; Pérez de Vega MJ
    Bioorg Med Chem; 2011 Dec; 19(24):7526-33. PubMed ID: 22078412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice.
    Katsara M; Deraos G; Tselios T; Matsoukas J; Apostolopoulos V
    J Med Chem; 2008 Jul; 51(13):3971-8. PubMed ID: 18563891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive activity of hymenistatin I.
    Cebrat M; Wieczorek Z; Siemion IZ
    Peptides; 1996; 17(2):191-6. PubMed ID: 8801520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.